M
itral valve degeneration is a common cardiac valve disorder that involves mitral valve prolapse and myxomatous mitral valve disease. The underlying genetic variations and mechanisms of mitral valve degeneration are still elusive. 1 Mitral valve degeneration occurs when mitral valve leaflets become too long, thick, floppy, and eventually unable to function properly. Mitral valve degeneration progresses toward mitral valve regurgitation (MR), cardiac insufficiency, endocarditis, arrhythmia, and ultimately congestive heart failure. 2 The adult mitral valve is made up of highly organized extracellular matrix (ECM) and valve interstitial cells (VICs) with an outer layer of valve endocardial cells (VECs). In the adult aortic leaflet (also known as anterior leaflet) of the mitral valve, the VICs originate largely from the overlaying endocardium, whereas in the mural leaflet (also known as posterior leaflet), they originate largely from the epicardium. 3, 4 During valve degeneration and disease, the cellular and ECM composition of the valve changes. 5, 6 Atrioventricular valve formation starts at embryonic day 9.5 in mice when locally the ECM that separates the endocardial and myocardial cells in the atrioventricular canal 7, 8 expands and forms atrioventricular cushions. 9, 10 Bmp2, secreted from the atrioventricular myocardium, renders the overlaying endocardial cells competent to undergo endocardial-to-mesenchymal transition (EndoMT) 11, 12 and induces the expression of the transcription factor Twist1. 13 Notch signaling determines which endocardial cells undergo EndoMT and induces the expression of Snail1. 14, 15 Snail1 suppresses the expression of vascular endothelial cadherin in the endocardial cells 14, 16 and is required for Snail2 expression. 17 Twist1 further downregulates vascular endothelial cadherin and upregulates N-cadherin, allowing endocardial cells to undergo EndoMT. Tgfβ2 further regulates the dislodgement of the endocardial cells from the epithelial context, their transition into a mesenchymal phenotype, and migration into the ECM. 11, 18 The mesenchymal cells express Snail1, Snail2 and Twist1, 14, 15 and proliferate. 19 The endocardial cells that do not undergo EndoMT express the transcription factor Nfatc1 and do not express Snail1 and Snail2. and show a stratified structure, comprising of atrialis, spongiosa, and fibrosa layers. 23 The atrialis, at the atrial side of the leaflet, is rich in radially-oriented elastin fibers, the spongiosa, in the center of the leaflet, is rich in proteoglycans and glycosaminoglycans, and the fibrosa, at the ventricular side, is composed of densely packed collagen fibers.
Fstl1 (Follistatin-like 1), also known as Tgfβ-stimulated clone-36, 24 is a secreted glycoprotein belonging to the Follistatin and SPARC (secreted protein, acidic and rich in cysteine) family of proteins 25 and is a potential prognostic marker for cardiovascular disease. 26, 27 Fstl1 expression is induced by Tgfβ and thought to be an extracellular regulator of Bmp signaling. [28] [29] [30] During cardiac development, Fstl1 is highly expressed in the nonmyocardial component of the heart and at a lower level in the myocardium itself. 28, 31, 32 It is of relevance to note that macrophages and monocytes are immunohistochemically positive for Fstl1, but do not express Fstl1. 33 Homozygous deletion of Fstl1 results in death at birth because of an inability to breathe; the neonates show an extensive array of skeletal, cardiac, and respiratory defects. 29, 30 Conditional deletion of Fstl1 from the cardiomyocytes using αMHC-Cre 34 or from the nonmyocardial component using S100A4-Cre (Fsp1) 35 results in viable offspring with no obvious abnormalities. Inducing pressure overload in such cardiomyocytespecific Fstl1 KO mice reduces hypertrophic growth of the cardiomyocytes and antagonizes loss of ventricular function. 34 Contrastingly, a permanent ligation of the left anterior descending coronary artery in the nonmyocyte-specific Fstl1 KO results in increased mortality because of cardiac rupture. 35 Applying an epicardial collagen patch loaded with Fstl1 to an infarct zone stimulates cell cycle entry and proliferation of preexisting cardiomyocytes, improving cardiac function and survival. 36 To further analyze the role of Fstl1 in the nonmyocardial component of the heart, we created an endocardial/endothelialspecific Fstl1 KO using Tie2-Cre. We observed that almost all mice die between 2 and 4 weeks after birth. Functional analysis showed MR and heart failure with preserved ejection fraction (HFpEF). Histological and echocardiographic analysis of the valves revealed long and thick incompetent mitral valves with a myxomatous phenotype, in which active Bmp and Tgfβ signaling persists. In the enlarged valve leaflets, markers of EndoMT are upregulated, and the proliferation rate of VECs and VICs is increased; together they contribute to the enlargement of the mitral valves.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results
Mice were generated in which Fstl1 was conditionally deleted from the endothelial/endocardial cell lineage, using the Tie2-Cre driver line. 37 Crossing males which are heterozygous knock out for Fstl1 and heterozygous for the Tie2-Cre allele (Fstl1 KO/WT Tie2Cre ) with females that are homozygous for the floxed Fstl1 allele and heterozygous for the mT/mG reporter (Fstl1 fl/fl mT/mG ) resulted in 125 pups that were born healthy and in Mendelian ratios. The cKO (Fstl1 KO/fl Tie2Cre ) pups started to die from postnatal day (PN) 14 onward; by PN21, 69% and by PN35, 97% of the pups had died ( Figure 1A) ) pups died during this period. In the further analysis, we only compared control with cKO pups. The body weight of the cKO pups was significantly decreased at PN14 and PN21 ( Figure 1B ). Autopsy showed that these cKO pups had enlarged hearts ( Figure 1C and 1D ), expressing the cardiac stress marker atrial natriuretic factor (Nppa) in the left ventricle (LV) only ( Figure  IA through ID in the online-only Data Supplement). Mitral valves were abnormal from PN10 onward ( Figure 1E through 1J). From PN14 onward, the valve leaflets billowed into the atrium and had nodules at their distal ends (arrows, Figure 1H and 1J). The tricuspid valve was morphologically affected as well but to a lesser extent than the mitral valves. The semilunar valves did not show any functional abnormalities. Based on these findings, we focused the analysis on the mitral leaflets only. Because in diseased valves the ECM is often disorganized, collagen and acid-polysaccharides were visualized using sirius red and alcian blue staining, respectively. For both compounds, the pattern was different in the cKO compared with the control (arrows, Figure 1E through IJ; Figure II in the online-only Data Supplement).
Visualization of the expression pattern of Fstl1 in the postnatal and adult valves showed that Fstl1 mRNA is expressed in both leaflets of the mitral valve and preferentially at the atrial side in the endocardial lining and flanking mesenchyme ( Figure 1K and IN) . Although the recombination pattern of Tie2-Cre has been extensively described, 3, 4 we validated the recombination pattern in our cKO mice using the mT/mG reporter, 4 which is present in the homozygous Fstl1 floxed mouse line. In line with previous studies, GFP (green fluorescent protein) expression was identified in the endocardial lining of the mitral leaflets, in most of the mesenchymal cells of the aortic leaflet and in only a small portion of the mesenchymal cells in the mural leaflet ( Figure  IIIA through IIIF in the online-only Data Supplement). The GFP expression shows successful recombination and as such identifies the population of cells from which Fstl1 was removed. Immunofluorescent visualization of Fstl1 in the control and cKO pups showed that in controls, Fstl1 protein is found in both valve leaflets. In the cKO, Fstl1 is absent from the aortic leaflet, whereas a subset of mesenchymal cells underlying the endocardium at the atrial side of the mural leaflet still expresses Fstl1 ( Figure 1O through 1T). After birth, Tie2-Cre is also active in a subset of macrophages; 38 therefore, we evaluated whether the macrophage population in the cKO leaflets differed from the controls using the pan-macrophage marker Cd68. In both the control and cKO leaflets, a similar small number of Cd68-expressing WT/fl mice and cKO for Fstl1 KO/fl Tie2Cre mice. The survival curve of cKO (A) shows that these mice (red line) start to die from postnatal day (PN) 14 onward; two thirds have died by PN21 and all are dead by PN90. The control (blue line) and heterozygous mice (gray line) all survive until PN90. The body weight (B) of control (blue bars) and cKO mice (red bars) was similar at PN7 and significantly lower for cKO mice at PN14 and PN21. Data are presented as mean±SEM. t test was performed between the groups (n=3; each time point and group). Autopsy revealed enlarged hearts in cKO mice (C and D). Picro sirius red staining of sections of PN10, PN14, and PN23 hearts (E through J) showed abnormal long and thick mitral valve leaflets in cKO hearts. In situ hybridization was performed on PN7, PN14, and PN21 adult control hearts (K through N) to visualize the mRNA expression of Fstl1 (blue). At all ages, Fstl1 mRNA is expressed in the valve endocardial cells (VECs) and a subset of valve interstitial cells (VICs) of both mitral valve leaflets. Immunofluorescent staining was performed on the control and cKO hearts at PN7 and PN21 (O through T) to visualize the presence of Fstl1 (green) and Cd31 (red) protein. At PN7 (O) and PN21 (Q and S), Fstl1 is expressed in both leaflets in the control. In these leaflets, Fstl1 is mainly expressed in the VECs and a subset of VICs. In cKO hearts, Fstl1 is almost completely absent from the aortic leaflet (P and R). In the mural leaflet (P and T) of the cKO, a large number of scattered VICs expressing Fstl1 can be identified. Cd31 expression was found throughout the entire endocardial lining of both control and cKO valve leaflets (O through T). Scale bar in C and D indicate 2 mm; E-J, 250 µm; K-N, 125 µm; O-T, 50 µm. AL indicates aortic leaflet; LA, left atrium; LV, left ventricle; ML, mural leaflet; RA, right atrium; RV, right ventricle; and VS, ventricular septum.
macrophages were present at the atrial side of leaflets, suggesting that deletion of Fstl1 using Tie2-Cre did not affect the macrophage population in the valve leaflets ( Figure  IVA through IVF in the online-only Data Supplement). Immunofluorescent staining of Cd31 showed that the integrity and continuity of endothelium was similar in both leaflets in control and cKO hearts ( Figure 1O through 1T ).
Progressive MR
Six litters (57 pups) were systematically evaluated with respect to heart function and structure using echocardiography and 2-dimensional color Doppler for 23 days after birth (Table) . At PN23, all pups were euthanized and genotyped. After genotyping, only the data from the cKO and control pups were included in the analysis. Till PN7, none of the pups showed echocardiographic abnormalities, but from PN10 onward, abnormal diastolic-systolic movements and MR started to become evident in the cKO pups (echo Movie I and II in the online-only Data Supplement). Three of 15 cKO pups showed MR at PN10, an additional 2 pups at PN14, another 4 at PN16, and another 6 at PN23 (Figure 2A through 2E) . One of the 15 cKO pups did not show MR or other echocardiographic abnormalities at the end of the experiment as did all of the control pups. Two of the pups showing MR at PN10 had died at PN14 and the third one was found dead on PN16. At PN23, 3 of the pups that had developed MR at PN16 were found dead. These observations point to a progressive development of mitral valve disease. For further analyses, the cKO pups at each time point were grouped into 2 categories, pups without MR (cKO−MR) and with MR (cKO+MR). In the statistical analysis, both cKO groups were compared with the controls and with each other. All the cKO+MR pups showed an increase in LV volume during diastole flow into the LV filling and the E/A ratio (ie, the ratio of the early [E] to late [A] ventricular filling velocities), substantiating diastolic dysfunction and mitral valve regurgitation ( Figure 2F ).
From PN14 onward, the LV mass of all cKO+MR pups was increased significantly compared with cKO−MR and control pups, which were not different ( Figure 2G ). In line with this finding, the LV stroke volume was significantly increased in cKO+MR pups from PN10 onward compared with cKO−MR pups and controls ( Figure 2H ). Further assessment of LV systolic and diastolic variables showed a significant increase in LV internal diameter and LV volume in cKO+MR pups in diastole from PN10 onward and in systole from PN14 onward ( Most of the cKO−MR pups clustered with the controls. A few, however, showed a tendency to cluster with the cKO+MR group; the latter are the pups that developed MR in the following days. The cKO+MR pups that showed the highest values for LV volume in diastole were found dead during the following days. Calculating the fractional shortening ( Figure IVB in the online-only Data Supplement) and ejection fraction ( Figure 2N ) did not reveal any significant differences between the different groups and time points. These findings in combination with the significant increase in LV stroke volume point to an overload of the LV that is most probably because of mitral dysfunction. It is of relevance to note that none of the right ventricular echocardiographic parameters (data not shown) showed significant changes in either cKO group compared with the control groups.
Effects of Fstl1 cKO on the Cardiac Conduction System
ECGs were recorded because cardiac conduction system abnormalities were anticipated. It has been shown that Fstl1 affects the function of the sodium/potassium ATPase channel (Atp1a1), 39 which is essential for the function of cardiac conduction system. Moreover, the conduction system is isolated from the surrounding myocardial tissue by endocardial-derived mesenchymal cells. 3, 40 ECG analysis showed that the R-R interval-a measure for sinus rhythm-and PR interval-a measure for the conduction through the atrioventricular node and bundle-were not significantly different between control and cKO pups, indicating that cardiac conduction is not affected ( Figure 3A and 3B). The P amplitude was observed to decrease during normal postnatal development, whereas this decrease was delayed in the cKO−MR pups and did not occur in cKO+MR pups ( Figure 3C ). The significantly larger P amplitude at PN23 in cKO+MR pups was in line with the enlargement of the atria observed at autopsy ( Figure 1C through 1D ). The ECG analysis further uncovered significant effects on the QRS and QT intervals ( Figure 3D and 3E), measures of ventricular function. The QRS interval was significantly prolonged from PN14 onward in cKO+MR pups compared with cKO−MR and control pups, the Echocardiography and electrocardiography were performed on the pups without knowledge of the genotype. After completion of the experiment at PN23, the genotype was determined. The table summarizes the number of pups analyzed echocardiagraphically and electrocardiographically at the different days after birth. From PN10 onward, some of the cKO pups develop MR, and, therefore, the cKO pups were divided in a group without MR (cKO−MR) and with MR (cKO+MR). MR indicates mitral regurgitation; and PN, postnatal day.
latter were not significantly different ( Figure 3D ). Moreover, in halve of the cKO+MR pups, fragmentation of the QRS complex was observed at PN23 ( Figure 3F ). Fragmentation of the QRS complex points to aberrant repolarization of the ventricles. This was further substantiated by the finding that the QT interval was significantly increased in the cKO (shown by purple dashed line) compared with controls ( Figure 3E ), being 29% longer in cKO−MR pups and 11% in cKO+MR pups.
Elongation of the Mitral Valve Leaflets
To document the abnormal mitral valves, a morphometric analysis of the aortic and mural leaflets was performed in control and cKO+MR pups at PN23. The volume of the valve leaflets was significantly larger in cKO+MR compared with controls, with the aortic leaflet being 3-fold larger and the mural leaflets being almost 2-fold larger ( Figure 4A ). The number of nuclei in each leaflet, which reflects the number of cells because VICs and VECs are mononuclear, showed similar differences ( Figure 4B ). The average valve volume per nucleus, calculated by dividing the valve volume by the number of nuclei in each leaflet, was not significantly different between the aortic and mural leaflet and in the cKO+MR and control pups ( Figure 4C ; Figure XIIE and XIIF in the online-only Data Supplement). From this, we concluded that there is hardly any effect of deletion of Fstl1 on the amount of ECM deposited per cell.
The increase in volume of the valves might be because of an increase in the length or the thickness of the leaflets or both. Measuring the length of the leaflets revealed that the aortic leaflet of cKO+MR pups was twice as long as those in controls ( Figure 4D ), whereas the length of the mural leaflet was not significantly different. The aortic leaflet of cKO+MR pups is not only longer but also ≈2× thicker than in controls ( Figure 4E ). The mural leaflet of cKO+MR pups, on the contrary, showed an additional peak on top of the distribution of the thickness values found in control pups ( Figure 4F ). This second peak points to an almost 3× thicker region within the leaflet. Histological analysis identified a nodule at the distal end of the leaflet, which is far more pronounced in the cKO+MR than in control (arrow, Figure 1F , 1H, and 1J). The difference in the response of the leaflets to Tie2-Cre mediated deletion of Fstl1 is most probably because of the fact that endocardial-derived cells are predominantly found in the aortic leaflet and hardly in the mural leaflet. 4, 41 Moreover, immunofluorescent staining of the valve leaflets for Fstl1 in the cKO showed that there were hardly any cells expressing Fstl1 in the aortic leaflet ( Figure 1R ), whereas a subset of VICs located below the endocardial lining at the atrial side of the mural leaflet was expressing Fstl1 (Figure 1T ).
Altered ECM and Cytoskeletal Components in cKO Mitral Valve
Enlarged dysfunctional mitral valves are often related to an altered ECM composition. 42 Therefore, the expression of different ECM proteins was analyzed at PN23 in cKO+MR and control valves. Evaluation of Col1a1 (collagen 1a1) and Col3a1, which provide rigidity to the adult valves and are dysregulated during valve disease, 43 showed that Col3a1 mRNA was highly expressed in a large portion of the VICs and VECs lining the leaflet of the controls, whereas Col1a1 was only found in a small set of VICs scattered throughout the leaflets. In cKO+MR pups, the expression of Col3a1 was more extensive in the aortic leaflet than in the controls, whereas the expression in the mural leaflet was not different from controls ( Figure 5A through 5D ). The expression of Col1a1 was not different between control and cKO+MR pups (data not shown).
Fibrillin1-an ECM glycoprotein 44, 45 -was barely detectable in the leaflets of the control but strongly expressed in a large subset of the VECs and VICs in both leaflets in the cKO+MR. Moreover, the expression was more extensive in the aortic leaflet than in the mural leaflet ( Figure 6A  through 6C ).
Versican-a proteoglycan that mediates ECM organization 46 -was found as described 47 in the VECs at the atrial side of the leaflets and in VICs at the distal end of the aortic leaflet in the controls ( Figure 5E ). In cKO+MR pups, versican was abundantly expressed throughout the entire leaflets except for small regions that were devoid of its expression (arrowheads, Figure 5F and 5G).
Periostin-a secreted ECM protein mediating the interaction between the ECM and integrins at the cell surface-was expressed in the VECs and at the atrial side of the nodules of both leaflets in controls ( Figure 5H ). In the cKO+MR, periostin was abundantly and broadly expressed throughout the valve leaflets, except for some small regions containing VICs (arrowheads, Figure 5I and 5J). Table. e122
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Filamin-A, which conveys signals of the ECM from integrins to the actin cytoskeleton, 48, 49 was found in the VECs at the atrial side of the leaflet in controls ( Figure 5K ), whereas in cKO+MR pups, its expression was found throughout the entire endocardial lining of the leaflets and in immediately adjacent mesenchymal cells (arrow and arrowheads, Figure 5L and 5M).
Next, we evaluated proteins suggested to be EndoMT markers. Laminin, an integral part of the basement membrane is expressed in a subset of the VECs, overlying the nodule in control leaflets ( Figure 5N) . 22 In cKO+MR, it was barely detectable in the aortic leaflet, whereas it was expressed throughout the entire endocardial lining of the mural leaflet (arrow, Figure 5O and 5P). The valve volume per nucleus (C) is similar in both leaflets of control and cKO+MR mice. At PN23, the aortic leaflet is 2× longer in cKO+MR (red dots) than in control mice (blue dots); the mural leaflets are of similar length (D). There is a significant difference in the cKO+MR aortic leaflet length as compared with the mural leaflets of both control and cKO+MR mice. The distribution of the thickness of the valve leaflets (E and F) shows that in both leaflets, the modal thickness is around 50 µm but that the aortic leaflet (E) has more regions of increased thickness and a nodule with an average thickness of just >100 µm. The frequency distribution of thicknesses of the mural leaflet (F) shows 2 peaks in the cKO+MR mice (red line) compared with 1 peak in the control (blue line), pointing to the presence of a nodule of around 150-µm diameter (arrow). Data are presented as mean±SEM. Statistical analysis was performed by 2-way ANOVA. Post hoc test was performed by t test between the groups (n=3; per leaflet of control and cKO+MR mice). A and B) . In the cKO+MR mice (C and D), the expression of Col3a1 mRNA seems to be downregulated in the mural leaflet as compared with the aortic leaflet. The arrows point to regions of the valve leaflet that are devoid of Col3a1 mRNA expression. Versican (green) is expressed in the endocardial lining at the atrial side of the leaflets and in valve interstitial cells (VICs) at the distal end of the aortic leaflet in control mice (E); all nuclei are shown in red. In cKO+MR mice (F and G), versican is abundantly expressed throughout the leaflet (arrows), but some areas were devoid of expression (arrowheads) in both leaflets. Periostin is expressed in both endocardial cells and VICs at the atrial side of the nodules of both leaflets in control mice (H). In cKO+MR mice (I and J), Periostin is abundantly expressed (arrows), but some regions containing VICs were devoid of the expression (arrowheads) in both leaflets. Filamin A is expressed only in the endocardial cells at the atrial side of the leaflet in control mice (K), whereas filamin A is expressed throughout the entire endocardial lining (arrows) and in immediately adjacent mesenchymal cells (arrowheads) of both leaflets in cKO+MR mice (L and M). Laminin is expressed in a subset of endocardial cells, overlying the nodule of the leaflets in control mice (N), whereas Laminin is uniformly expressed throughout the entire endocardial lining (arrows) of both leaflets in cKO+MR mice (O and P). Vimentin is expressed in the outer endocardial lining and atrial nodules of both leaflets in control mice (Q). In both leaflets of cKO+MR mice (R and S), however, Vimentin is broadly expressed in the endocardial lining (arrows) and in a large subpopulation of VICs (arrowheads). αSma is expressed only in a few scattered mesenchymal cells throughout the leaflets in control mice (T), whereas αSma is expressed in the endocardial cells (arrows) and the immediate adjacent mesenchymal cells (arrowheads) of both leaflets in cKO+MR mice (U and V). The micrographs are representative images of the staining patterns observed in 3 different animals per genotype. The scale bar in A through D indicates 50 µm; in all other panels, it indicates 100 µm. αSma indicates α-smooth muscle actin; AL indicates aortic leaflet; and ML, mural leaflet.
Vimentin-an intermediate filament protein present in motile cells-was found in the endocardial lining and atrial nodules of control leaflets ( Figure 5Q ), whereas its expression had expanded to almost all VICs in cKO+MR leaflets (arrowheads, Figure 5R and 5S).
Another cytoskeletal marker for motile cells, αSma (α-smooth muscle actin), 5 was found in a few scattered VICs in controls ( Figure 5T ), whereas in the cKO+MR, αSma expression was found in small patches of VECs and adjacent VICs (arrow and arrowhead, Figure 5U and 5V).
Spatio-Temporal Expression of Key Transcription Factors in Valve Development
The changes in ECM and cytoskeletal proteins suggest that EndoMT contributes to the enlargement of the valve leaflets in the cKO+MR. To further evaluate this option, we determined the expression pattern of various transcription factors involved in EndoMT. Snail1 (Snai1), Snail2 (Snai2/Slug), and Twist1 50,51 were expressed at low levels, if any, in the leaflets of control pups, whereas in cKO+MR pups, extensive expression was found in a large subset of the VECs overlaying the leaflets and adjacent VICs. The expression pattern was broader in the aortic leaflet compared with the mural leaflet (arrows and arrowheads, Figure 6D through 6L).
Expression of Sox9 was found throughout in a large portion of the VICs and VECs in both control and cKO+MR pups ( Figure Taken together, these findings might point to a delay in the developmental downregulation of EndoMT in the absence of Fstl1, resulting in larger valve leaflets. . In both leaflets of cKO+MR mice (E and F), Snail1 expression is found in a small subset of the endocardial cells (arrows) overlaying the leaflets and adjacent VICs (arrowheads). Snail2 mRNA expression is below detection in the valve leaflets of the control mice (G). In both leaflets of cKO+MR mice (H and I), a large subset of valve endocardial cells (arrows) and adjacent VICs (arrowheads) express Snail2. Twist1 mRNA expression is not detectable in the valve leaflets of control mice (J) and is expressed mainly in the endocardial cells (arrows) of both leaflets of cKO+MR mice (K and L). Bmp2 mRNA is expressed in the endocardial lining facing the atrium in control mice (M). It is intensely stained in the endocardial cells overlying both sides of the leaflets (arrows) and a subset of VICs (arrowheads) in both the leaflets of cKO+MR mice (N and O). In the control mice, Tgfβ1 mRNA is detected in a subset of the endocardial lining (arrow) overlying the valve leaflets in control mice (P), whereas in cKO+MR mice (Q and R), Tgfβ1 mRNA is not only detected in a subset of the endocardial cells (arrows) but also in VICs (arrowheads) in both leaflets. The micrographs are representative images of the staining patterns observed in 3 different animals per genotype. All micrographs are shown at the same magnification, and the scale bar indicates 50 µm. MR indicates mitral regurgitation. e125
cKO Mice Exhibit Increased Activity of Bmp and Tgfβ Signaling
Both Bmp and Tgfβ growth factors are crucial regulators of valve development, in particular EndoMT, and also in cardiovascular disease. 50, 52 In control mice, Bmp2 is expressed only in the VECs at the atrial side of the leaflets (Figure 6M ), whereas its expression was found throughout the entire endocardial lining of both valve leaflet cells and in a large subset of the VICs of the cKO+MR (arrow and arrowheads, Figure 6N and 6O) . Normally, Tgfβ1 is expressed in scattered VECs of the leaflets at birth. 53 In controls at PN23, Tgfβ1 expression is hardly detectable in VECs of the valve leaflets (arrow, Figure 6P ). In the cKO+MR group, the expression is higher and not limited to the endocardial lining but also found in a subset of VICs of the leaflets (arrow and arrowhead, Figure 6Q and 6R). The expression of Tgfβ2 was not found to be different between control and cKO+MR pups (data not shown).
To evaluate whether Bmp or Tgfβ signaling are active after birth and altered in the cKO+MR, the expression of pSmad1/5 and pSmad2/3 were immunofluorescently visualized in the leaflets at different postnatal stages ( Figure VII in the onlineonly Data Supplement). For clarity, we show not only an image of pSmad1/5 and pSmad2/3 staining alone but also in combination with cTnI and Dapi. At PN5, pSmad1/5 was found in most, if not all, nuclei of the VECs lining the leaflets. (A and D) . In the aortic leaflet of cKO+MR mice (B and E), pSmad1/5 is expressed in the entire endocardial lining (arrows) and in adjacent valve interstitial cells (VICs; arrowheads). In the mural leaflet of cKO+MR mice (C and F), the expression is similar to the expression in the leaflets of control mice (arrows). In the control leaflets, pSmad2/3 is expressed throughout the endocardial lining (G and J). In both leaflets of cKO+MR mice (H through L), pSmad2/3 is expressed abundantly in the endocardial cells (arrows) and VICs (arrowheads). The micrographs are representative images of the staining patterns observed in 3 different animals per genotype. The scale bar indicates 50 µm. AL indicates aortic leaflet; and ML, mural leaflet.
As development proceeds, the number of VECs expressing pSmad1/5 gradually decreased (arrows, Figure VIIA through VIIIF in the online-only Data Supplement; Figure 7A and 7D) . In cKO+MR pups, pSmad1/5 was observed in the entire endocardial lining and in adjacent VICs of the aortic leaflet at PN23 (arrows and arrowheads, Figure 7B and 7E). The fraction of pSmad1/5 positive cells in the aortic leaflet was significantly increased in the cKO+MR as compared with control ( Figure  VIIIA and VIIIC in the online-only Data Supplement). In the mural leaflet, the expression of pSmad1/5 was found to be more intense in the endocardial lining of the cKO+MR (arrows, Figure 7C and 7F), but the fraction of pSmad1/5 cells was not Figure 8 . Quantification of proliferation of valve cells in the mitral valve leaflets. Ki67 immunofluorescence staining was used to identify cells that are in the cell cycle at postnatal day (PN) 1, PN7, PN14, and PN21. The number of nuclei was quantified in the mitral valve leaflets of control (blue lines) and cKO mice, which from 14 days after birth showed mitral regurgitation (cKO+MR; red lines). The total number of nuclei, including both valve endocardial cells (VECs) and valve interstitial cells (VICs), in the aortic (A) and mural (C) leaflets increases during postnatal development. At PN14, the aortic leaflet of cKO+MR mice contains significantly more cells than that of the control mice, whereas at PN21, both the aortic and mural leaflets of cKO+MR mice contain more cells. The fraction of Ki67-positive valve cells in the aortic leaflet (B) decreases >2-fold during development in both the control and the cKO+MR valves but is ≈5% higher until PN21 in the cKO+MR mice. The fraction of Ki67-positive cells in the mural leaflet (D) decreases >2-fold in both control and cKO+MR mice and does not differ significantly between genotypes. The diagrams (E) show a schematic representation of the proposed mechanism of action of Fstl1 in the development of the valves. This model is described in the discussion. The black diagram shows the mechanism that is operational during normal development. The red diagram indicates the changes that are found upon disruption of Fstl1 from the endocardial/ endothelial lineage using Tie2-Cre. Data are presented as mean±SEM. Statistical analysis was performed by 2-way ANOVA with a post hoc t test per age (n=3 for each leaflet at each time point). ECM indicates extracellular matrix. At PN5 in control mice, pSmad2/3 was identified in most nuclei of the VECs and in a large portion of the VICs of both leaflets (arrows and arrowheads, Figure VIIG and VIIH in the online-only Data Supplement). Progressively, the number of pSmad2/3 positive cells decreased, and the expression became restricted to a subset of the VECs overlaying the leaflets at PN23 (arrows, Figure VII I through VIIL in the online-only Data Supplement; Figure 7G and 7J). In cKO+MR pups, pSmad2/3 was present in most, if not all, VECs and in a large portion of VICs in both the aortic and mural leaflet at PN23 (arrows and arrowheads, Figure 7H through 7L). In the aortic and mural leaflet of the cKO+MR, there is a significant increase in the total number of pSmad2/3 positive cells; the fractions are, however, not significantly different between the different leaflets of control and cKO+MR (Figure VIIIE through VIIIH in the onlineonly Data Supplement). These observations indicate that active Tgfβ signaling is not downregulated in the valve of the cKO+MR mice during postnatal development, like it is in the control. We also looked at the coexpression of pSmad1/5 and pSmad2/3 in the valve leaflets and found that a subset of VECs do express both pSmad1/5 and pSmad2/3 in cKO and in control (arrows, Figure IXA through IXD in the online-only Data Supplement). The VICs are mostly positive for pSmad2/3, although a few individual double pSmad1/5 and pSmad2/3 positive VICs can be identified adjacent to the endocardial lining (arrowheads, Figure  IXC and IXD in the online-only Data Supplement).
Taken together, these findings suggest that EndoMT remains operational in the mitral valve leaflets of the cKO+MR.
cKO Mice Show More Proliferation in Mitral Leaflets
Although our analyses, thus far, suggest that the enlargement of the leaflets points to persistent EndoMT in the cKO+MR pups, an increased proliferation rate of the valve cells might also contribute to the enlarged leaflets. 54, 55 To identify and determine the number of valve cells that are in the cell cycle, sections were stained using Ki67 at PN1, PN7, PN14, and PN21 and quantified ( Figure XA through XP in the online-only Data Supplement). In line with previous reports, 54, 55 the number of valve cells in cell cycle in control mice decreased from ≈15% to 5%, and there was no significant difference between the aortic and mural leaflets ( Figure 8B and 8D ). In the mural leaflet of the cKO+MR, the fraction of cells in cell cycle is not significantly different from the control at any of the developmental stages evaluated. In the aortic leaflet of the cKO+MR pups, however, the fraction of cells in cell cycle was similar to those of the control at PN21, but at the earlier time points, the fraction was always ≈5% higher than in the control. (Figure 8B ), suggesting that proliferation of valve cells contributed to the enlargement of the aortic leaflet. Because we found that the leaflets are comprised for two thirds (67±4%) of Sox9 positive cells, we also determined whether either of these populations were preferentially proliferating ( Figure XIIK through XIIN in the online-only Data Supplement). Both populations followed the same developmental decrease as the total population, which indicates that Fstl1 deletion from the Tie2-lineage affected both the Sox9 positive and negative populations in a similar way.
Discussion
Development of the atrioventricular valves is a complex process, including the formation of endocardial cushions and their transition into embryonic valve leaflets, which after birth mature and elongate into slender adult leaflets. Bmp and Tgfβ growth factor signaling pathways play an important role in pre-and postnatal development of the valve leaflets. Fstl1-a natural inhibitor of Bmp signaling 29 and induced by Tgfβ signaling 24 -is expressed in the endocardial lining and mesenchymal cells of the atrioventricular valves throughout development. Fstl1 becomes restricted mainly to the VECs and VICs at the atrial side of the atrioventricular valves after birth. These findings suggest a potential role of Fstl1 in valve development, maturation, and disease. Global and conditional deletion of Fstl1 had not uncovered a valve phenotype, thus far. 29, 30, [34] [35] [36] To explore the role of Fstl1 in valve development, Fstl1 was conditionally deleted from the endocardial/endothelial cell lineage using the Tie2-Cre driver. Pups from which Fstl1 was conditionally deleted are referred to as cKO pups. They were found to die between 2 and 4 weeks after birth. Although these pups looked and behaved normal, they became smaller in body size and sluggish compared with their littermates in the days before their death. Autopsy revealed enlarged hearts and large deformed mitral valves (Figure 1) .
Echocardiographic analysis showed that in the second week after birth, the mitral valves became deformed with a myxomatous phenotype and dysfunctional MR. The fact that the LV inner diameter and volume in systole and diastole (Figure 2 ) increased significantly without a change in the thickness of the ventricular wall and interventricular septum (Figure 2 ; Figure  IVA in the online-only Data Supplement) points to cardiac dilation. Along with these structural changes, also the ventricular function became compromised. ECG analysis showed widening and fragmentation of the QRS complex and the lengthening of the QTc (Figure 3) , suggesting aberrant repolarization of the ventricles and development of heart failure. Together with the finding that the ejection fraction did not change ( Figure 2N ), these pups showed HFpEF. The finding that E/A was also significantly increased in cKO+MR hearts ( Figure 2F ) further documents diastolic dysfunction and supports the diagnosis of HFpEF. Recently, it was reported that HFpEF accounts for ≤50% of all heart failure cases, and Fstl1 was suggested to play an important role in HFpEF by regulating hypertrophy. 35 The ventricular phenotype might be secondary to the valve phenotype. On the contrary, it might also be a direct effect because of the absence of Fstl1 from the endocardium and endocardial-derived interstitial cells within the ventricle. Such a direct role in the ventricle is not unlikely because Fstl1 was found to regulate hypertrophy after transaortic constriction 56 and to stimulate regeneration of the infarcted myocardium through activation of cardiac fibroblasts. 36 The absence of Fstl1 from the ventricular endocardium in cKO might impair ventricular formation and its hypertrophic response and as such ameliorate the dysfunction of the atrioventricular valves.
To establish how Fstl1 deletion from endocardial/endothelial lineage affects postnatal mitral valve development, the dimensions of the leaflets were determined. The volume of the dysfunctional mitral valve leaflets was significantly larger as a result of significant longer and thicker leaflets ( Figure 4A and 4D through 4F). The total number of valve cells had increased proportionally with the valve volume, which indicates that there was no excessive deposit of ECM ( Figure 4B ). The changes are more pronounced in the aortic leaflet than in the mural leaflet. This difference is most probably because of the fact that the VICs in the aortic leaflet are mainly endocardial-derived, whereas those in the mural leaflet are mainly epicardial-derived after birth. 4 Apparently, the remaining expression of Fstl1 in the epicardial-derived VICs in the mural leaflet is enough to partly preserve valve form and function ( Figure 1P and 1T) .
We hypothesized that the larger number of cells in the mitral leaflets is because of increased proliferation of the VICs and sustained EndoMT ( Figure 8E ). Bmp and Tgfβ growth factor signaling pathways are major driving factors behind mitral valve formation and homeostasis. 10, 22, [57] [58] [59] Bmp signaling renders the VECs competent to undergo EndoMT, and Tgfβ regulates the transition of the endocardial cells into mesenchymal cells and their migration in the underlaying tissue. 50 The overlap of both pSmad1/5 and psmad2/3 in a subset of VECs in the cKO+MR is suggestive of active EndoMT. Because Fstl1 is an extracellular inhibitor of Bmp signaling 29 and its expression is induced by Tgfβ, 24 we hypothesized that ablation of Fstl1 removes the inhibition on Bmp signaling; therefore, results in a larger valve leaflet because of an increase in proliferation of the valve cells and sustained EndoMT (Figures 5, 6 , and 8). Moreover, Bmp2 induces and maintains the expression of Tgfβ2, which in turn activates proliferation of quiescent adult VICs. 50 Indeed, in the valve leaflets of the cKO, the expression of Bmp2 mRNA was more extensively expressed in the endocardial lining and in the valve cells than in the controls ( Figure 6M through 6O) . Also, the expression of Tgfβ1 mRNA was found to be extensively expressed in the valve cells of the cKO ( Figure 6P through 6R) , which point toward EndoMT. This increase in Bmp and Tgfβ signaling in the cKO valves was accompanied by associated changes in the expression patterns of pSmad1/5 and pSmad2/3. These findings support our hypothesis that proliferation and EndoMT underlies the enlargement of valves in the cKO heart.
The finding that Bmp signaling in the cKO remains substantially more active in the postnatal VECs and is found in adjacent VICs suggests that the VECs remain competent to undergo EndoMT. The enhanced active Tgfβ signaling would further support EndoMT. The finding that the expression pattern of the transcription factors Snail1, Snail2, Twist1, and Sox9 (Figure 6D through 6L; Figure X in the online-only Data Supplement), which are downstream targets of Bmp and Tgfβ signaling and crucial for EndoMT, 15 was induced or broader in the VECs and the adjacent VICs in the cKO valve leaflets. This further underscores the persistence of EndoMT in the cKO. During the process of EndoMT, ECM and cytoskeletal proteins need to be expressed to allow dislodgement of the cells from their endocardial context and differentiation into migratory mesenchymal cells. The observed changes in the expression patterns of versican, laminin, and periostin support dislodgment of the endocardial cells from their epithelial context and migration as mesenchymal cells into the valve leaflet. 60 We also observed that the intracellular proteins filamin-A, fibrillin, vimentin, and αSma were upregulated in a subset of the valve cells, pointing to a motile phenotype of the mesenchymal cells in the valve leaflets. 61 Taken together, these changes in gene expression on depletion of Fstl1 from Tie2-Cre lineage point to sustained EndoMT, as a mechanism that underlies the observed abnormally large and thick incompetent valve leaflets.
An alternative mechanism to obtain enlarged valve leaflets is increased proliferation of the valve cells. The 5% larger fraction of cells in cell cycle observed in the cKO at PN1, PN7, and PN14 can account for an 1.8-fold increase in the number of cells at PN23 when a cell cycle time of 24 hours is assumed. Therefore, a contribution of increased proliferation to the enlarged valve leaflets cannot be excluded.
Taken together, these findings along with the findings on EndoMT suggest that EndoMT underlies the enlargement of both the aortic and mural leaflets and that the additional increase in size, comparing the aortic and mural leaflets, is most likely because of an increase in proliferation of the valve cells. The finding that the rate of proliferation was not different between the Sox9 positive and Sox9 negative population of valve cells shows that proliferating valve cells do not belong to a specific lineage.
Concluding Remarks
We report on a mouse model in which deletion of Fstl1 from the endocardial/endothelial lineage results in abnormal mitral valve leaflets. The abnormal valve becomes apparent from the second week after birth only. The valve leaflets become long and thick and eventually display a myxomatous phenotype. The enlargement of the valve leaflets is because of sustained Bmp and Tgfβ signaling, leading to a delayed postnatal downregulation of proliferation and EndoMT. Echocardiographic analysis showed that the abnormal mitral valve becomes incompetent, resulting in mitral valve regurgitation. Before death, the cKO pups develop cardiac dilation and HFpEF, as documented by echocardiographic and electrocardiographic analyses.
